MedTrace Logo

Effectiveness of Prolonged Use of IUD/Implant for Contraception

NCT02267616 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 1076

Last updated 2021-04-15

No results posted yet for this study

Summary

This study will evaluate LNG-IUD and Etonogestrel (ENG) Implant users who are willing to use their contraception beyond the end of the FDA-approved duration. ENG Implant users will also be offered to participate in an arm of the study that will randomize them to either keeping their implant in or having it removed and replaced with a new implant. Participants will be followed for up to three years.

Conditions

  • Contraception

Interventions

DEVICE

Etonogestrel Implant

Subdermal arm implant

Sponsors & Collaborators

  • Susan Thompson Buffett Foundation

    collaborator UNKNOWN

  • Indiana University

    lead OTHER

Principal Investigators

  • Jeffrey F Peipert, MD, PhD · Indiana University

Study Design

Allocation
RANDOMIZED
Purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
45 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2011-12-31
Primary Completion
2021-03-31
Completion
2021-03-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02267616 on ClinicalTrials.gov